secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K/A
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001689548-26-000016
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis assigns Kindler to Audit/Nominating, Arbuckle to Comp/Science & Tech; amends director comp policy
--------------------------------------------------------------------------------

- Jeffrey B. Kindler appointed to Audit Committee and Nominating and Corporate Governance Committee effective Feb 6, 2026.
- Stuart A. Arbuckle appointed to Compensation Committee and Science and Technology Committee effective Feb 6, 2026.
- Board amended Non-Employee Director Compensation Policy; cash retainers: $50k board, $40k chair, plus committee chair/member fees.
- New directors received initial RSUs ($220k) and pro-rata option/RSUs; annual awards: $110k option + $330k RSU for continuing directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000168954826000016/0001689548-26-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000168954826000016/prax-20260206.htm
  HTML page:      https://secwatch.observer/filing/0001689548-26-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer